Arbutus Biopharma Corp
ABUS | NASDAQ
$5
$0 (0.00%)
Sep 22, 2026, 10:33 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -5.14M | 169.7M | -3.76M | -7.74M | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -16.34M | -21.93M | -17.57M | -14.19M | -15.77M | -21.32M | -19.16M | -19.39M | -16.38M |
Depreciation & Amortization | 11K | 11K | 11K | 11K | 11K | 330K | 333K | 336K | 356K | 355K | 359K | 369K | 342K | 334K | 307K | 343K | 383K | 394K | 427K | 447K | 436K | 443K |
Stock-Based Compensation | 1.63M | 1.36M | 1.26M | 1.26M | 864K | 3.56M | 1.63M | 2.16M | 3.18M | 2.01M | 1.72M | 2.48M | 2.96M | 2.13M | 1.67M | 1.72M | 2.06M | 1.74M | 1.43M | 1.62M | 1.74M | 1.64M |
Other Working Capital | -530K | -179.04M | 1.93M | 1.03M | -18.4M | -503K | 572K | -2.66M | 2.39M | -472K | 1.09M | -3.83M | -3.21M | -4.65M | 3.03M | -1.33M | -10.72M | 37.26M | 242K | 249K | 414K | -973K |
Other Non-Cash Items | -275K | -1.29M | -4M | -499K | -907K | 1.97M | 481K | -1.02M | -1M | -930K | -1.55M | -1.15M | -1.77M | -1.09M | -546K | -1.78M | -935K | -488K | -1.39M | 13K | 604K | 144K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 241K | n/a | n/a | n/a |
Change in Working Capital | -2.24M | -177.88M | 1.8M | 1.15M | -18.24M | 5.27M | -229K | -2.5M | 2.76M | -2.86M | 1.49M | -3.38M | -4M | -12.33M | 3.51M | -1.4M | -7.61M | 34.74M | 1.01M | 1.05M | 2.6M | -3.72M |
Operating Cash Flow | -6.02M | -8.11M | -4.68M | -5.82M | -15.75M | -13.39M | -10.32M | -20.74M | -14.5M | -19.3M | -17.29M | -21.78M | -19.56M | -27.3M | -16.99M | -18.69M | -20.29M | 20.62M | -19.61M | -16.04M | -14.01M | -17.88M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -86K | -410 | -1K | -95K | 12.66K | -32K | -859K | -117K | -134K | -91K | -212K | -75K | -58K | -20K | -632K | -99K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.19M | n/a | n/a | n/a | 37M | n/a | n/a | n/a | n/a | 1.81M | n/a | n/a | n/a |
Purchase of Investments | -23.66M | -13.8M | -25.55M | -51.3M | -28.5M | -34.72M | -43.19M | -40.34M | -32.59M | -25.4M | -24.02M | -7.09M | -29.2M | -20.21M | -13.16M | -32.65M | -22.64M | -61.98M | -28.06M | -11K | -52.12M | -2.03M |
Sales Maturities Of Investments | 22M | 16M | 23.83M | 41.28M | 44.1M | 46.07M | 56.69M | 28.35M | 42.42M | 37.19M | 46.24M | 17.53M | 31.5M | 37M | 26M | 19M | 9M | 2M | 20M | 16M | 14M | 20.35M |
Other Investing Acitivies | 1K | -1K | 355K | n/a | n/a | n/a | n/a | n/a | n/a | -37.19M | n/a | 20K | n/a | -37M | -20K | n/a | 20K | n/a | -1.81M | n/a | n/a | n/a |
Investing Cash Flow | -1.66M | 2.2M | -1.36M | -10.02M | 15.61M | 11.35M | 13.41M | -11.99M | 9.83M | 11.69M | 22.23M | 10.43M | 1.44M | 16.68M | 12.68M | -13.74M | -13.83M | -60.06M | -8.12M | 15.97M | -38.75M | 18.22M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.14M | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 1.42M | n/a | 2.01M | 2.67M | -45K | 285K | n/a | 555K | 1K | 159K | 113K | 11.22M | 12.02M | 2.22M | 15K | 455K |
Financial Cash Flow | 3.15M | 11.62M | 1.64M | 844K | 453K | 2.78M | 1.42M | 1.78M | 24.37M | 24.43M | 3.81M | 1.68M | 4.74M | 20.42M | 11.08M | 9.13M | 113K | 11.49M | 59.12M | 46.95M | 4.29M | 26.87M |
Net Cash Flow | -4.54M | 5.7M | -4.4M | -15M | 336K | 746K | 4.48M | -30.94M | 19.69M | 16.82M | 8.75M | -9.67M | -13.38M | 9.8M | 6.77M | -23.32M | -34.01M | -27.95M | 31.4M | 46.93M | -48.47M | 27.17M |
Free Cash Flow | -6.02M | -8.11M | -4.68M | -5.82M | -15.75M | -13.39M | -10.4M | -20.74M | -14.51M | -19.39M | -17.29M | -21.82M | -20.42M | -27.42M | -17.12M | -18.78M | -20.51M | 20.54M | -19.66M | -16.06M | -14.64M | -17.98M |
Adj. Free Cash Flow | -7.64M | -9.47M | -5.94M | -7.08M | -16.61M | -16.96M | -12.03M | -22.9M | -17.69M | -21.4M | -19.02M | -24.3M | -23.38M | -29.55M | -18.79M | -20.5M | -22.57M | 18.81M | -21.1M | -17.67M | -16.38M | -19.62M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -86K | -410 | -1K | -95K | 12.66K | -32K | -859K | -117K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -134K | -91K | -212K | -75K | -58K | -20K | -632K | -99K |
Owner Earnings | -6.02M | -8.11M | -4.68M | -5.82M | -15.75M | -13.39M | -10.4M | -20.74M | -14.51M | -19.39M | -17.28M | -21.82M | -20.42M | -27.42M | -16.99M | -18.69M | -20.29M | 20.62M | -19.61M | -16.04M | -14.01M | -17.88M |
Add to Watchlist
Select watchlists to add or remove ABUS